Frailty Predicts Survival and Toxicity in Newly Diagnosed Multiple Myeloma Patients Ineligible for Autologous Stem Cell Transplantation; Report of the HOVON-87/Nmsg-18 Study Group

Autor: Stege, C A M, Van Der Holt, B, Mellqvist, U H, Levin, M D, Salomo, M, Abildgaard, N, Bos, G, Visser-Wisselaar, H, Hansson, M, Van Der Velden, A, Deenik, W, Gruber, A, Coenen, J L L M, Plesner, T, Klein, S, Tanis, B, Szatkowski, D L, Brouwer, R, Westerman, M, Leijs, M B, Sinnige, H, Haukaas, E, Van Der Hem, K, Durian, M, Mattijssen, V, Gimsing, P, Van De Donk, N W C J, Stevens-Kroef, M, Sonneveld, P, Waage, A, Zweegman, S

Publikováno v: Stege, C A M, van der Holt, B, Mellqvist, U-H, Levin, M-D, Salomo, M, Abildgaard, N, Bos, G, Visser-Wisselaar, H, Hansson, M, van der Velden, A, Deenik, W, Gruber, A, Coenen, J L L M, Plesner, T, Klein, S, Tanis, B, Szatkowski, D L, Brouwer, R, Westerman, M, Leijs, M B, Sinnige, H, Haukås, E, van der Hem, K, Durian, M F, Mattijssen, V, Gimsing, P, Van De Donk, N WCJ, Stevens-Kroef, M, Sonneveld, P, Waage, A & Zweegman, S 2017, ' Frailty Predicts Survival and Toxicity in Newly Diagnosed Multiple Myeloma Patients Ineligible for Autologous Stem Cell Transplantation; Report of the HOVON-87/Nmsg-18 Study Group ', Blood, vol. 130, no. Suppl. 1, 3146 . < http://www.bloodjournal.org/content/130/Suppl_1/3146.full?sso-checked=true >
Stege, C A M, Van Der Holt, B, Mellqvist, U H, Levin, M D, Salomo, M, Abildgaard, N, Bos, G, Visser-Wisselaar, H, Hansson, M, Van Der Velden, A, Deenik, W, Gruber, A, Coenen, J L L M, Plesner, T, Klein, S, Tanis, B, Szatkowski, D L, Brouwer, R, Westerman, M, Leijs, M B, Sinnige, H, Haukaas, E, Van Der Hem, K, Durian, M, Mattijssen, V, Gimsing, P, Van De Donk, N W C J, Stevens-Kroef, M, Sonneveld, P, Waage, A & Zweegman, S 2017, Frailty predicts survival and toxicity in newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation; report of the HOVON-87/NMSG-18 study group . in Blood. Conference: 59th Annual Meeting of the American Society of Hematology, ASH . Blood. Conference: 59th Annual Meeting of the American Society of Hematology, ASH, vol. 130 . < http://www.bloodjournal.org/content/130/Suppl_1/3146 http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=620335289 >
Stege, C A M, Sonneveld, P, Plesner, T, Stevens-Kroef, M, van der Holt, B, Zweegman, S, Waage, A, Klein, S, Sinnige, H, Mellqvist, U-H, Abildgaard, N, Durian, M F, Hansson, M, Levin, M-D, Leijs, M B, Szatkowski, D L, Haukås, E, Salomo, M, Bos, G, Visser-Wisselaar, H, van der Velden, A, Deenik, W, Gruber, A, Coenen, J L L M, Tanis, B, Brouwer, R, Westerman, M, van der Hem, K, Mattijssen, V, Gimsing, P & Van De Donk, N WCJ 2017, ' Frailty Predicts Survival and Toxicity in Newly Diagnosed Multiple Myeloma Patients Ineligible for Autologous Stem Cell Transplantation; Report of the HOVON-87/Nmsg-18 Study Group ', 59th Annual Meeting and Exposition of the American Society of Hematology December 9-12th 2017, Atlanta, USA , Atlanta, United States, 09/12/2017-12/12/2017 .
Blood. Conference: 59th Annual Meeting of the American Society of Hematology, ASH

Introduction We previously reported the results of the phase III randomized HOVON-87/NMSG-18 study for Newly Diagnosed Multiple Myeloma patients not eligible for stem cell transplantation (nte-NDMM). The efficacy of melphalan, prednisolone and either

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::de954831a83b2ea33933ff13b8607d91
http://www.bloodjournal.org/content/130/Suppl_1/3146.full?sso-checked=true

P905: IXAZOMIB‐THALIDOMIDE‐DEXAMETHASONE INDUCTION FOLLOWED BY IXAZOMIB OR PLACEBO MAINTENANCE IN NON‐TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS; LONG‐TERM RESULTS OF HOVON‐126/NMSG 21.13.

Autor: Groen, K., Seefat, M. R., van der Holt, B., Schjesvold, F. H., Stege, C. A., Levin, M.‐D., Hansson, M., Leys, R. B., Regelink, J., Waage, A., Szatkowski, D., Axelsson, P., Do, T. H., Svirskaite, A., van der Spek, E., Haukas, E., Knut‐Bojanowska, D., Ypma, P. F., Blimark, C., Mellqvist, U.‐H.

Publikováno v: HemaSphere; 2022 Supplement 3, Vol. 6, p796-797, 2p

FrontMatter.

Autor: Barnaure, I., Barreiro-Cotón, S., Issels, R. D., Kasch, R., Neβelmann, C., Schaps, K. -P., Szatkowski, D., Gräfin zu Toerring-Jettenbach, A.

Publikováno v: Innere Medizin (9783540463504); 2007, pI-XXXII, 32p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pharmaceutical Grade Ge/Ga-68 Generator.

Autor: Szatkowski, D., Kim, S. H., Jefferies, T.

Publikováno v: Health Physics; 2022 Supplement, Vol. 122, p64-64, 1/9p